Telix Publishes ProstACT SELECT Study on TLX591-Tx
Melbourne, Australia & Indianapolis, Indiana, USA | July 22, 2026 Telix Pharmaceuticals announced the peer-reviewed publication of results from...
Telix
Advertisement
Telix Opens Australia’s First Integrated Radiopharmaceutical Facility for Cancer Care
MELBOURNE, Australia & INDIANAPOLIS, Ind., July 16, 2026 Telix has officially opened Telix Manufacturing Solutions North Melbourne (TMSNM), Australia’s...
Telix Secures FDA Alignment to Advance ProstACT Phase 3 Trial
Melbourne, Australia, and Indianapolis, Indiana, United States, July 2, 2026 Telix announced a significant regulatory milestone after a successful...
Telix and Varian Launch Theranostics-EBRT Precision Oncology Collaboration
Melbourne, Australia & Palo Alto, CA – December 10, 2025 – Telix Pharmaceuticals Limited and Varian, a Siemens Healthineers...
Advertisement
